Vyome Holdings, Inc. (HIND) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HIND SEC filings page.
Vyome Holdings, Inc. (HIND) reported $130K in revenue over the twelve months to Jun 30, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Development-stage economics dominate: modest revenue is overwhelmed by operating costs, with financing supplying the cash needed for continued investment.
The business produced$319.7K of revenue in FY2025 while spending$588.3K on R&D, yet operating losses reached$10.5M ; this is an investment model whose cost base is disconnected from current sales. Revenue improved from FY2024, but operating margin deteriorated from-391.7% to-3,269.4% , indicating that the higher sales base did not absorb fixed operating costs.
Gross margin fell from
The balance sheet shifted from negative equity and a
Financial Health Signals
Vyome Holdings, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Vyome Holdings, Inc. scores -20.46, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($14.5M) relative to total liabilities ($2.7M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Vyome Holdings, Inc. passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Vyome Holdings, Inc. reported a net loss of $10.3M while operations used $3.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Vyome Holdings, Inc. reported an operating loss of $10.5M against $147K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Vyome Holdings, Inc. generated $27K in revenue in Q2 2026. This represents a decrease of 46.0% from the same quarter a year earlier. Against the prior quarter it is down 14.7%.
Vyome Holdings, Inc.'s EBITDA was -$860K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 167.7% from the same quarter a year earlier. Against the prior quarter it is up 23.7%.
Vyome Holdings, Inc. reported -$686K in net income in Q2 2026. This represents a decrease of 122.0% from the same quarter a year earlier. Against the prior quarter it is up 28.8%.
Vyome Holdings, Inc. earned -$0.10 per diluted share (EPS) in Q2 2026. Against the prior quarter it is up 33.3%.
Cash & Balance Sheet
Vyome Holdings, Inc. held $7.9M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Vyome Holdings, Inc.'s gross margin was 43.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 5.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.4 percentage points.
Vyome Holdings, Inc.'s ROE was -9.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. Against the prior quarter it is up 2.6 percentage points.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Vyome Holdings, Inc. invested $507K in research and development in Q2 2026. This represents an increase of 532.9% from the same quarter a year earlier. Against the prior quarter it is down 24.0%.
Not reported for Q2 2026.
Not reported for Q2 2026.
HIND Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $27K-46.0% | $32K-84.1% | $37K | $35K-59.0% | $50K-97.5% | $199K-89.8% | N/A | $85K-96.1% |
| Cost of Revenue | $15K-40.5% | $15K-66.2% | $14K | $17K-65.1% | $26K-96.9% | $44K-94.3% | N/A | $47K-94.5% |
| Gross Profit | $12K-51.9% | $17K-89.2% | $22K | $18K-51.3% | $24K-97.9% | $154K-86.7% | N/A | $37K-97.1% |
| R&D Expenses | $507K+532.9% | $666K+638.3% | $378K | $40K-40.6% | $80K-79.9% | $90K-81.3% | N/A | $67K-87.7% |
| SG&A Expenses | $365K+37.5% | $478K+83.9% | $996K | $844K+242.1% | $265K-60.4% | $260K-74.5% | N/A | $247K-86.2% |
| Operating Income | -$863K-166.1% | -$1.1M-467.8% | -$1.4M | -$8.6M-2951.6% | -$324K+84.2% | -$199K+91.0% | N/A | -$281K+92.8% |
| EBITDA | -$860K-167.7% | -$1.1M-476.7% | -$1.4M | -$8.6M-2999.4% | -$321K | -$195K+91.1% | N/A | -$277K+92.8% |
| Interest Expense | $3K-94.1% | $3K-94.8% | $10K | $26K-44.0% | $56K | $55K | N/A | $46K |
| Income Tax | N/A | N/A | N/A | N/A | $8K-46.7% | $7K-50.0% | N/A | $6K+100.0% |
| Net Income | -$686K-122.0% | -$963K-227.5% | -$1.2M | -$8.4M-1439.7% | -$309K+80.6% | -$294K+86.6% | N/A | -$548K+84.5% |
| EPS (Basic) | -$0.10+100.0% | -$0.15+100.0% | $5.14+100.2% | -$3.12-119.9% | -$799.90-873153.3% | -$761.59-562374.2% | -$3045.68-3517.9% | -$1.42+97.6% |
| EPS (Diluted) | -$0.10 | -$0.15 | $5.14+100.2% | -$3.12 | -$0.80 | -$761.59 | -$3045.68 | -$1419.10 |
| Diluted Shares (Avg) | N/A | 7M | N/A | 3M | 1M | 386 | N/A | 386 |
HIND Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.2M+464.4% | $10.2M+605.8% | $6.5M+370.3% | $7.0M+451.2% | $1.6M+17.9% | $1.4M-82.5% | $1.4M-87.0% | $1.3M-83.7% |
| Current Assets | $8.2M+1295.1% | $9.2M | $5.4M+1700.5% | $6.0M | $584K | N/A | $302K-97.1% | N/A |
| Cash & Equivalents | $7.9M+1957.3% | $8.8M | $5.0M+4789.2% | $5.7M+668.1% | $383K+3094.9% | N/A | $102K-97.7% | $743K-48.7% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | N/A | $0 | $0 |
| Accounts Receivable | $2K+539.6% | $309-100.0% | $325-85.8% | $23K-98.2% | $341-100.0% | $700K-56.3% | $2K-99.9% | $1.3M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | N/A | $0 | $0 |
| Total Liabilities | $1.9M-71.8% | $2.1M+906.2% | $2.7M-52.6% | $3.1M+1598.3% | $6.6M+23.7% | $213K-94.2% | $5.8M-65.7% | -$209K-104.4% |
| Current Liabilities | $1.9M-71.8% | $2.1M | $2.7M-52.3% | $3.1M-22.5% | $6.6M+106.3% | N/A | $5.7M+52.0% | $4.0M-9.9% |
| Non-Current Liabilities | $0-100.0% | $0 | $0-100.0% | $8K+100.2% | $17K-99.2% | N/A | $33K-99.7% | -$4.2M-1639.5% |
| Total Equity | $7.3M+246.4% | $8.0M+553.8% | $3.8M+185.7% | $2.5M+70.1% | -$5.0M-25.7% | $1.2M-72.9% | -$4.4M+28.9% | $1.5M-51.8% |
| Retained Earnings | -$89.2M-59.2% | -$88.5M+86.2% | -$87.6M-58.0% | -$86.3M+86.5% | -$56.0M+91.2% | -$641.2M-0.5% | -$55.4M+91.3% | -$640.9M-1.1% |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
HIND Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$904K-195.1% | -$1.4M-605.5% | -$1.5M-49704.5% | -$1.8M-370.7% | -$306K-116.7% | -$204K+90.2% | -$3K+99.9% | -$374K+86.5% |
| Depreciation & Amortization | $3K-12.1% | $3K-26.1% | $3K-30.4% | $3K-36.6% | $3K | $4K-41.3% | $4K-44.8% | $4K-91.1% |
| Stock-Based Compensation | N/A | $6K-62.0% | N/A | $574K+1694.1% | $12K-81.5% | $15K-79.2% | N/A | $32K-85.2% |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | $1K | $274 |
| Financing Cash Flow | -$3K-100.5% | $5.3M+3205.5% | $764K+1329.0% | $7.1M+2495.5% | $631K | $160K | $53K-99.0% | $274K+180.9% |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
HIND Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.3%-5.3pp | 52.7%-25.1pp | 60.4% | 52.1%+8.3pp | 48.5%-9.2pp | 77.8%+17.8pp | N/A | 43.9%-15.9pp |
| Operating Margin | -3200.0% | -3576.8% | -3707.3% | -24761.9% | -649.0% | -100.2% | N/A | -332.4% |
| Net Margin | -2543.3% | -3048.0% | -3352.6% | -24356.2% | -618.1% | -148.0% | N/A | -648.1% |
| Return on Equity | -9.4% | -12.0%+11.9pp | -32.6% | -333.4%-296.6pp | N/A | -23.9%+24.5pp | N/A | -36.8%+77.8pp |
| Return on Assets | -7.5%+11.5pp | -9.4%+10.9pp | -18.9% | -119.7%-76.9pp | -19.0%+96.7pp | -20.4%+6.3pp | N/A | -42.9%+2.3pp |
| Current Ratio | 4.37+4.3x | 4.27 | 1.99+1.9x | 1.94 | 0.09 | N/A | 0.05-2.7x | N/A |
| Debt-to-Equity | 0.26 | 0.27+0.1x | 0.73 | 1.24 | N/A | 0.17-0.6x | N/A | N/A |
| Asset Turnover | 0.000.0x | 0.00-0.1x | 0.01 | 0.00-0.1x | 0.03-1.4x | 0.14-0.1x | N/A | 0.07-0.2x |
Not reported in any period shown, so not listed: FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Vyome Holdings, Inc. HIND | FY2025 | $320K | -$10.3M | N/A | $14.5M | — |
| Tiziana Life Sciences Ltd. TLSA | FY2025 | N/A | -$18.4M | N/A | $122.2M | — |
| Tenaya Therapeutics, Inc. TNYA | FY2025 | N/A | -$90.6M | N/A | $143.5M | — |
| Cognition Therapeutics, Inc. CGTX | FY2025 | N/A | -$23.5M | N/A | $93.5M | — |
| MediWound Ltd. MDWD | FY2025 | $17.0M | -$23.9M | N/A | $169.3M | 17/100 |
| Entrada Therapeutics, Inc. TRDA | FY2025 | $25.4M | -$143.8M | N/A | $264.8M | 41/100 |
Where Vyome Holdings, Inc. Ranks
Frequently Asked Questions
What is Vyome Holdings, Inc.'s annual revenue?
Vyome Holdings, Inc. (HIND) reported $320K in total revenue for fiscal year 2025. This represents a 24.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Vyome Holdings, Inc.'s revenue growing?
Vyome Holdings, Inc. (HIND) revenue grew by 24.4% year-over-year, from $257K to $320K in fiscal year 2025.
Is Vyome Holdings, Inc. profitable?
No, Vyome Holdings, Inc. (HIND) reported a net income of -$10.3M in fiscal year 2025.
What is Vyome Holdings, Inc.'s EBITDA?
Vyome Holdings, Inc. (HIND) had EBITDA of -$10.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Vyome Holdings, Inc.'s gross margin?
Vyome Holdings, Inc. (HIND) had a gross margin of 68.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Vyome Holdings, Inc.'s return on equity (ROE)?
Vyome Holdings, Inc. (HIND) has a return on equity of -272.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Vyome Holdings, Inc.'s operating cash flow?
Vyome Holdings, Inc. (HIND) recorded an outflow of $3.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Vyome Holdings, Inc.'s total assets?
Vyome Holdings, Inc. (HIND) had $6.5M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Vyome Holdings, Inc. spend on research and development?
Vyome Holdings, Inc. (HIND) invested $588K in research and development during fiscal year 2025.
What is Vyome Holdings, Inc.'s current ratio?
Vyome Holdings, Inc. (HIND) had a current ratio of 1.99 as of fiscal year 2025, which is generally considered healthy.
What is Vyome Holdings, Inc.'s debt-to-equity ratio?
Vyome Holdings, Inc. (HIND) had a debt-to-equity ratio of 0.73 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Vyome Holdings, Inc.'s return on assets (ROA)?
Vyome Holdings, Inc. (HIND) had a return on assets of -157.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Vyome Holdings, Inc.'s P/E ratio?
Vyome Holdings, Inc. (HIND) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $14.5M as of Sep 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Vyome Holdings, Inc.'s price-to-sales ratio?
Vyome Holdings, Inc. (HIND) trades at 111x sales, its market capitalization divided by revenue of $130K revenue, trailing 12 months to June 30, 2026. The market capitalization is $14.5M as of Sep 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Vyome Holdings, Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Vyome Holdings, Inc. (HIND) held $5.0M in cash, cash equivalents and investments, and reported an operating cash outflow of $3.7M over that year. Dividing the one by the other, the reported balance equals about 16 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Vyome Holdings, Inc.'s Altman Z-Score?
Vyome Holdings, Inc. (HIND) has an Altman Z-Score of -20.46, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Vyome Holdings, Inc.'s Piotroski F-Score?
Vyome Holdings, Inc. (HIND) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Vyome Holdings, Inc.'s earnings high quality?
Vyome Holdings, Inc. (HIND) reported a net loss of $10.3M while operations used $3.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Vyome Holdings, Inc. cover its interest payments?
Vyome Holdings, Inc. (HIND) reported an operating loss of $10.5M against $147K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.